Niranjan Sardesai

Company: Geneos Therapeutics

Seminars:

Industry Leader’s Fireside Chat 11:00 am

An executive panel discussion from the C-level leaders of the field to set the scene on neoantigen based therapy development.Read more

day: Day Two

Personalized Cancer Vaccine for Treating Patients With Advanced Hepatocellular Cancer 10:30 am

GT-EPIC™ DNA plasmid product designed and manufactured for each patient based on their tumor specific neoantigens Discuss the interim clinical safety and efficacy data from the first 10 patients treated on study The use of immuno-monitoring to assess the potency of the personalized cancer vaccine and mechanism of action of the targeted neoantigens in the…Read more

day: Day Two

Panel Discussion: Examining the Impact of the Pandemic on Global Supply Chain to Gain Insight Into Next Strategy Steps 2:30 pm

Discussing strategy for producing cancer vaccines on an industrial scale under GMP conditions Exploring how companies have handled the low availability of raw materials (DNA vectors/ viral vectors) due to priority of Covid-19 for manufacturers Assessing the best strategy to deal with the logistical manufacturing issues that have arisen due to the pandemic Providing insight…Read more

day: Day Two Track B AM